AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference,...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a revolutionary new type of immunotherapy...
Despite advances in treatment, nearly 1,800 children and adolescents in the U.S. die annually from cancer. In an article...
For the second consecutive year, the American Association for Cancer Research (AACR) has been designated the beneficiary of Party...
Cancer cells ingest copious amounts of the simple sugar glucose. This addiction may hold the key to how cancer...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
Mubarak Labaran Liman has overcome the death of his father and a scarcity of resources to develop a thriving...
Scientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well...
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the breast cancer community just...
On Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss...